Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer
PaperCitations, authors & open-access status
Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 334 citations, 2014 year and green oa status.
334
Citations
2014
Year
green
OA Status